Abstract
In this study, differences in older patients between drug use as reported in clinical practice and in clinical trials for regulatory approval were examined. Electronic medical record (EMR) data such as patient background (age, sex), concomitant drugs, data on laboratory tests, and prescribed doses of drugs from outpatients with rheumatoid arthritis, diabetes, high blood pressure, or depression at Chiba University Hospital were obtained for the period from January 2003 to December 2012. These data were compared with data from relevant clinical trials for regulatory approval in order to examine differences in drug use. There were 5134 eligible patients. The prescribed doses of drugs were lower than the standard approved doses for depression and rheumatoid arthritis but were generally within the approved dose range for type 2 diabetes mellitus and hypertension. When comparing the characteristics of older patients taking tacrolimus, 5.6% to 17.0% of those would not be able to participate in clinical trials because of liver or renal abnormality, and the incidence rates of some adverse drug events (ADEs) differed significantly between clinical practice and clinical trials. Appropriate doses of drugs for older patients may differ from...Continue Reading
References
Dec 23, 1998·Japanese Journal of Clinical Oncology·Y Fujiwara
Dec 11, 2002·Journal of the American Geriatrics Society·Graziano OnderGiovanni Gambassi
Dec 18, 2003·British Journal of Clinical Pharmacology·Karin MartinNicholas Moore
Jan 30, 2004·British Journal of Clinical Pharmacology·P A RoutledgeK W Woodhouse
Jun 30, 2005·Journal of Clinical Pharmacy and Therapeutics·M TakadaM Shibakawa
Oct 4, 2005·Journal of the American College of Cardiology·Stephanie LäerMartin Hulpke-Wette
Mar 25, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K YonemoriS Toyoshima
Jan 14, 2011·The New England Journal of Medicine·Rachel E BehrmanRichard Platt
Feb 3, 2011·Journal of General Internal Medicine·Donna M ZulmanRodney A Hayward
Mar 8, 2011·Maturitas·C B Carroll, J P Zajicek
Apr 22, 2011·Clinical Pharmacology and Therapeutics·P F GallagherD O'Mahony
May 7, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Richard I Lindley
Nov 1, 2011·Pharmacoepidemiology and Drug Safety·Kevin V BlakeHenry Fitt
May 23, 2012·BMJ : British Medical Journal·Geoff Watts
May 31, 2012·Drugs & Aging·Eva TopinkováPierre-Olivier Lang
Jan 30, 2014·The Annals of Pharmacotherapy·Victor CrentsilAndre Jackson
Jun 3, 2014·The Journal of Nutrition, Health & Aging·Y AsahinaY Uyama
Dec 17, 2014·Modern Rheumatology·Ken-Ei SadaUNKNOWN Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan